PropertyValue
is ?:annotates of
?:authorAffiliation
  • [\'Department of Gynecological Oncology, Hubei Cancer Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan, China.\', \'Department of Radiation Oncology, Hubei Cancer Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan, China.\', \'Department of Radiation Oncology, Rutgers-Cancer Institute of New Jersey, Rutgers-Robert Wood Johnson Medical School, New Brunswick, NJ, USA.\']
?:citedBy
  • -1
?:creator
?:doi
?:doi
  • 10.1080/21645515.2021.1943988
?:hasPublicationType
?:journal
  • Human vaccines & immunotherapeutics
is ?:pmid of
?:pmid
?:pmid
  • 34170788
?:publication_isRelatedTo_Disease
?:rankingScore_SJR
  • -1.0
?:rankingScore_hIndex
  • -1
is ?:relation_isRelatedTo_publication of
?:title
  • COVID-19 vaccine development from the perspective of cancer patients.
?:type
?:year
  • 2021

Metadata

Anon_0  
expand all